InvestorsHub Logo
Followers 17
Posts 900
Boards Moderated 0
Alias Born 09/28/2014

Re: None

Monday, 04/20/2020 10:17:35 AM

Monday, April 20, 2020 10:17:35 AM

Post# of 704187

Of interest:

INmune Bio, Inc. Announces Initiation of Clinical Program Targeting Soluble TNF to Determine if the Company’s TNF Inhibitor (DN-TNF) Platform May Prevent Complications of Cytokine Storm Caused by COVID-19

https://www.inmunebio.com/index.php/en/news-2/2020/321-muneioncnnouncesnitiationoflinicalrogram20200420
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News